0b6ee1d7bb56499eb4dcbac11fe7b45851344b2c8f3648dcb11ff65b3a6fe6a37a639cdec0c44cf7ac36d3131abb86137b3a38ba7a1f4ca7a98a405bf3b00b09ad2597322fd54d539b3731b2bb02a369b62c0e8c880749399e115530e9508632c9d72f4d86b44e568f70beb3c4c8e80bdd41b72112a84edcb4e39e6afc0abff0df9c7c520e8f47b6b21de551754883c9f26a949290f64bbd891c9dd6cc30d186
agent
Effector T Helper Cells Are Selectively Controlled During Pregnancy and Related to a Postpartum Relapse in Multiple SclerosisSelective emergence of antibody-secreting cells in the multiple sclerosis brainDistinct Effector Programs of Brain-Homing CD8+ T Cells in Multiple SclerosisOcrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosisAbundant kif21b is associated with accelerated progression in neurodegenerative diseasesBrain-homing CD4+ T cells display glucocorticoid-resistant features in MSDifferential Runx3, Eomes, and T-bet expression subdivides MS-associated CD4+ T cells with brain-homing capacityImproving Glucocorticoid Sensitivity of Brain-Homing CD4+ T Helper Cells by Steroid Hormone CrosstalkA protocol for an intercomparison of biodiversity and ecosystem services models using harmonized land-use and climate scenariosThe association of Epstein-Barr virus infection with CXCR3+ B-cell development in multiple sclerosis impact of immunotherapies
author
nationality
type
label
Annet F Wierenga-Wolf
firstName
lastName
Wierenga-Wolf